Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

New Molecular Entities • None Changes in Labeled Indications • Opdivo® (nivolumab) and Yervoy® (ipilimumab) – FDA expanded the already approved indication for use of the two IO agents in combination to treat adult patients with unresectable or metastatic melanoma to now include use in treating pediatric patients 12 years of age or older. • Trodelvy® (sacituzumab …
If you are looking for legislative action, look no further than your state's legislatures. Most—if not all—states have had issues relating to oncology care and healthcare in general come up during their 2023 sessions.
New Molecular Entities • None Changes in Labeled Indications • Opdivo® (nivolumab) and Yervoy® (ipilimumab) – FDA expanded the already approved indication for use of the two IO agents in combination to treat adult patients with unresectable or metastatic melanoma to now include use in treating pediatric patients 12 years of age or older. • Trodelvy® (sacituzumab …
ACCC joins a broad coalition of patients, advocacy organizations, cancer centers, and healthcare professionals to express support for the Reducing Hereditary Cancer Act. This crucial piece of legislation would address unacceptable care gaps in Medicare beneficiary access to genetic testing for hereditary cancer risk, evidence-based screening, and risk-reducing interventions, when medically necessary …
Reducing Hereditary Cancer Act | Page 1 of 5 March 13, 2023 The Honorable Chuck Schumer Majority Leader U.S. Senate 322 Hart Senate Office Building Washington, DC 20510 The Honorable Mitch McConnell Minority Leader U.S. Senate 317 Russell Senate Office Building Washington, DC 20510 The Honorable Kevin McCarthy Speaker U.S. House of Representatives 2468 Rayburn …
March is Multiple Myeloma Awareness Month. Learn more about the work ACCC is doing to support oncology professionals in treating patients with this disease.
March 20, 2023
In the first webinar, we will hear from Sarah Hudson-DiSalle, PharmD, Rph, Pharmacy Manager, from The James Cancer Hospital, and Jordan Karwedsky, Financial Counselor from Green Bay Oncology. In this webinar, we discuss ACCC Prior Authorization Focus Group findings, payer recommendations, and how to best prepare for the prior authorization "blizzard" for next year.
March 20, 2023
This webinar will explore opportunities to expand multidisciplinary care collaboration and coordination to improve care for patients with non-melanoma skin cancers.
OUR MISSION: WEST VIRGINIA ONCOLOGY SOCIETY 1801 Research Blvd, Suite 400, Rockville, Maryland 20850 Phone: 301.984.9496 www.wvosinfo.com APPLICATION FOR MEMBERSHIP Annual membership dues (January 1–December 31) must accompany application. Mail payment with this form to: West Virginia Oncology Society; 1801 Research Boulevard, Suite …
Founded in 1991, the Rocky Mountain Oncology Society (RMOS) is a powerful community of multidisciplinary care providers involved in the treatment of patients with cancer. RMOS is a state Chapter Member of the Association of Community Cancer Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology. Members receive valuable educational content and innovative resources …
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia Electra D. Paskett, Ph.D. for the OSU CPHHD Supported by NCI Grant Number P50 CA105632 ▪ Grant funding to the Institution: ▪ Pfizer ▪ Merck Foundation ▪ Breast Cancer Research …
Appalachian Community Cancer Alliance Who We Are and What We Can Accomplish Friday March 24, 2023 Speaker Nicole L. Stout, DPT, CLT-LANA, FAPTA Research Assistant Professor West Virginia Cancer Institute West Virginia University School of Public Health Morgantown, WV Disclosure of Conflicts of Interest Nicole L. Stout, DPT, CLT-LANA, FAPTA, has no relevant …
CAR T-Cell Indications and Post-Treatment Care Salahuddin Safi, MD, MS Assistant Professor of Medicine Section of Hematology and Oncology West Virginia University Cancer Institute West Virginia Oncology Society Disclosures • None Objectives • Familiarize yourself with the basics of administering CAR T-cell therapy as well as general principles of CAR …
Disclosures and Conflict of Interest (COI) Mitigation Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: Ann Geiger, MPH, PhD; Borna Amir-Kabirian, MD; Bei Jiang, MD, PhD; Amir Kamran, MD, MS; Dan Lucas, PharmD; Surabhi Pathak, MD; Jared Reed, MD; Salah Ud Din Safi, MD; Anne Schnatterly, MBA, BSN, …
Treatment Clinic Model for the Oncology Patient Carrie Wines-Larch, BSN, RN, ONN-CG Nurse Navigator & Survivorship Coordinator Disclosures Carrie Wines-Larch, BSN, RN, ONN-CG, has no relevant financial relationships to disclose. TIME TRAVEL TIME! 9 SECTIONS WITH 17 STANDARDS REQUIRING ANNUAL REVIEW https://www.facs.org/quality- …
WellSpan Health embarked on a multispecialty effort to reimagine the management and care of patients with incidental findings, thereby optimizing population health, lowering the cost of care, and improving the patient and provider experiences.
Through a collaboration between legal and healthcare professionals, this Virginia based medical-legal partnership assists patients with cancer resolve social and environmental factors that contribute to health disparities.
ACCC’s online course provides cancer care team members with the tools needed to be clear and concise in communication with patients, build awareness and skills regarding health literacy, and improve health equity.
Key findings from an ACCC survey and education program.
issues 6 OI | Vol. 38, No 1, 2023 | accc-cancer.org States Poised to Continue Banning Co-Pay Accumulators in 2023 BY MATT DEVINO, MPH The last several years have seen a marked increase in state and federal policy seeking to address the cost and affordability of prescription drugs. One area of particular interest to state legislatures in 2021, 2022, and again in 2023 are co-pay …